Karen Pendergrass

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Recent Posts

2025-08-22

Role of Iron in Bacterial Pathogenesis: Clinical Takeaways from an Editorial

What was reviewed? This editorial synthesizes evidence on the role of iron in bacterial pathogenesis, emphasizing how iron scarcity and host nutritional immunity shape virulence, metabolic strategy, and antibiotic tolerance across diverse pathogens. Mechanisms covered include siderophore production and piracy, heme acquisition, ferrous iron uptake via Feo, and regulatory circuitry such as Fur and the […]

2025-08-22

Plasma Iron Infection Risk: Role of TSAT and HFE C282Y in Immune Defense

This review summarizes evidence that both low and high plasma iron increase infection risk, particularly in individuals with HFE C282Y homozygosity. Maintaining stable transferrin saturation is vital for immune function, with implications for managing hemochromatosis and iron deficiency to prevent infections and support microbiome health.

2025-08-11

Pseudomonas aeruginosa

Overview Pseudomonas aeruginosa is the most clinically significant species within the diverse Pseudomonas genus, known for being Glyoxalase I (Glo-I) and oxidase-positive. It is a versatile Gram-negative bacterium and a major opportunistic pathogen, frequently causing hospital-acquired infections such as pneumonia and bacteremia, particularly in immunocompromised individuals. Its pathogenicity is driven by a wide array of […]

2025-08-11

Retrograde Menstruation Theory

Retrograde menstruation theory holds that during menstruation, some endometrial tissue reverses through the fallopian tubes into the pelvic cavity. It implants on pelvic organs, thickens, breaks down, and bleeds cyclically, causing inflammation, pain, and scar tissue, characteristic of endometriosis.

2025-08-11

Pueraria Flower Extract (PFE)

Pueraria lobata (kudzu) is used in traditional medicine for cardiovascular issues, menopause, and alcohol dependence due to its bioactive isoflavones. These compounds, particularly puerarin, offer vasodilatory effects and antioxidant properties, enhancing blood circulation and reducing oxidative stress.

2025-08-11

Cholestyramine

Cholestyramine, a polymer resin, binds bile acids, toxins, and heavy metals, reducing cholesterol and fat absorption, while altering gut microbiome and aiding detoxification.

2025-08-11

Heart Failure

Recent research reveals that the gut microbiome significantly influences heart failure progression, contributing to inflammation and other complications.

2025-08-11

Bacterial Vaginosis

Bacterial vaginosis (BV) is caused by an imbalance in the vaginal microbiota, where the typically dominant Lactobacillus species are significantly reduced, leading to an overgrowth of anaerobic and facultative bacteria.

2025-08-11

Oxidase Positive

Oxidase positivity in an organism refers to the ability of the organism to produce the enzyme cytochrome c oxidase, which is involved in the electron transport chain during aerobic respiration.

2025-08-11

Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer

What was studied? This study investigated the gut microbiota profiles, diagnostic value, and functional pathways specific to premenopausal breast cancer patients. It aimed to identify unique gut microbial markers distinguishing premenopausal breast cancer patients from postmenopausal patients and age-matched controls. The study also explored functional pathways of gut microbiota linked to breast cancer progression and […]

2025-08-11

Causal effects of gut microbiome on endometriosis: a two-sample Mendelian randomization study

What was studied? This study investigated the causal relationship between gut microbiome composition and endometriosis using a two-sample Mendelian randomization (MR) approach. The researchers aimed to determine whether specific gut microbiota taxa have a direct causal effect on endometriosis risk rather than a mere observational association. Who was studied? The study utilized genome-wide association study […]

2025-08-11

Metformin

Metformin is a synthetic derivative of guanidine derived from the guanidine alkaloid of the plant Galega officinalis L. with significant hypoglycemic effects. It is a first-line antihyperglycemic agent due to its efficacy, low cost, and favorable safety profile.

2025-08-11

Research Fast-Track (RFT) Designation

Overview The Research Fast-Track (RFT) designation is a priority label used within the Microbiome Signatures framework to identify microbiome-targeted interventions that demonstrate exceptional translational potential and clinical relevance. This designation highlights interventions that warrant accelerated research, validation, and collaborative exploration due to their alignment with condition-specific microbiome signatures and their capacity to impact disease pathogenesis […]

2025-08-01

Urine metallomics signature as an indicator of pancreatic cancer†

This study identifies a distinct urinary metallomic signature in pancreatic cancer patients, marked by altered calcium, magnesium, copper, and zinc levels, along with lighter zinc isotopic composition. These findings suggest that non-invasive urine tests could enable early PDAC detection by leveraging trace metal imbalances and stable isotope shifts.